Insight Molecular Diagnostics Inc.
IMDX Nasdaq
SEC CIK 1642380
Follow Insight Molecular Diagnostics
Weekly email: filings, results
Revenue, last quarter
$559K
+115% vs same quarter last year
Net income
−$3.6M
+67% vs same quarter last year
EPS, diluted
−$0.10
+70.6% vs same quarter last year
Operating cash flow
−$6.4M
−39.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $4.1M | −$50.2K |
| FY24 | $1.9M | −$60.7K |
| FY23 | $1.5M | −$27.8K |
| FY22 | $958K | −$72.9M |
| FY21 | $2.2M | −$64.1M |
| FY20 | $1.2M | −$29.9M |
| FY19 | - | −$22.4M |
| FY18 | - | −$15.8M |
| FY17 | - | −$19.4M |
| FY16 | - | −$11.2M |
| FY15 | $0 | −$8.7M |
| FY14 | - | −$5M |
| FY13 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 56.7% | −1260.8% | −1.2% |
| FY24 | 39.3% | −3245.1% | −3.2% |
| FY23 | 27.5% | −1672.4% | −1.8% |
| FY22 | −1.9% | −1878.6% | −7609.8% |
| FY21 | 64.6% | −2444.3% | −2916.2% |
| FY20 | −52.5% | −2443.3% | −2461.5% |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
| FY14 | - | - | - |
| FY13 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$25.4M |
| FY24 | −$21.2M |
| FY23 | −$23.6M |
| FY22 | −$49.9M |
| FY21 | −$38.2M |
| FY20 | −$27.2M |
| FY19 | −$20.6M |
| FY18 | −$11.7M |
| FY17 | −$13.5M |
| FY16 | −$7.6M |
| FY15 | −$4.7M |
| FY14 | −$1.2M |
| FY13 | - |
- Insight Molecular Diagnostics
- Healthcare median
Show the numbers
| Year | Insight Molecular Diagnostics | Healthcare median |
|---|---|---|
| FY25 | −1.2% | −30.6% |
| FY24 | −3.2% | −47% |
| FY23 | −1.8% | −58% |
| FY22 | −7609.8% | −80.4% |
| FY21 | −2916.2% | −71.9% |
| FY20 | −2461.5% | −62.2% |
| FY19 | - | −46.3% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −38.4% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |